NEW YORK (Reuters Health) - In cancer patients accidentally overexposed with the chemotherapy drug 5-fluorouracil (5-FU), the drug vistonuridine (Wellstat Therapeutics Corp) may be lifesaving, according to research to be reported June 1 at the American Society of Clinical Oncology’s annual meeting in Orlando.
